Animalcare Group’s (ANCR) “Buy” Rating Reaffirmed at Panmure Gordon

Animalcare Group (LON:ANCR)‘s stock had its “buy” rating reaffirmed by equities researchers at Panmure Gordon in a research report issued to clients and investors on Monday. They presently have a GBX 429 ($5.82) target price on the stock. Panmure Gordon’s price objective would suggest a potential upside of 47.67% from the stock’s previous close.

Animalcare Group (ANCR) opened at GBX 290.52 ($3.94) on Monday. The stock has a market capitalization of $167.26 and a price-to-earnings ratio of 2,641.09. Animalcare Group has a 1-year low of GBX 290 ($3.93) and a 1-year high of GBX 460 ($6.24).

TRADEMARK VIOLATION WARNING: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at

Animalcare Group Company Profile

Animalcare Group plc is a United Kingdom-based sales, marketing and product development company. The Company is principally engaged in the development, sale and distribution of licensed veterinary pharmaceuticals and identification products and services to companion animal veterinary markets. The Company develops and sells goods and services to veterinary professionals principally for use in companion animals, operating through the United Kingdom wholesalers and distribution and development partners in markets in Western Europe.

Receive News & Ratings for Animalcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Animalcare Group and related companies with's FREE daily email newsletter.

Leave a Reply